Insider · CIK 0001851964

Venezia Rocco

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001851964

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	Chief Accounting Officer	UDisposition from Tender	−10.8K sh	$19.00	−$205K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−14.7K sh	$19.00	−$279K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−6,100 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−16K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−1,996 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−54 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−746 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−454 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−504 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−1,696 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−728 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−592 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−2,950 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−5,500 sh	—	—	0
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	Chief Accounting Officer	AAward	+9,800 sh	—	—	25,451
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Chief Accounting Officer	AAward	+16K sh	—	—	16,000
2022-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−675 sh	$12.37	−$8,349.75	15,651
2022-09-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−429 sh	$18.06	−$7,747.74	16,326
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	Chief Accounting Officer	AAward	+3,600 sh	—	—	16,755
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Chief Accounting Officer	AAward	+6,100 sh	—	—	6,100
2022-01-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−35 sh	$16.29	−$570.15	13,155
2021-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−515 sh	$16.29	−$8,389.35	13,190
2021-10-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−30 sh	$15.22	−$456.6	13,705
2021-09-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−524 sh	$15.05	−$7,886.2	13,735
2021-07-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−30 sh	$20.47	−$614.1	14,259
2021-04-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	Chief Accounting Officer	FTax Payment	−29 sh	$24.28	−$704.12	14,289

Recent filings

Accepted (ET)
Nov 134
Venezia Rocco0001104659-23-117117
SEC(opens sec.gov)
Jan 314
Venezia Rocco0001104659-23-008594
SEC(opens sec.gov)
Jan 34
Venezia Rocco0001104659-23-000338
SEC(opens sec.gov)
Sep 64
Venezia Rocco0001104659-22-097846
SEC(opens sec.gov)
Jan 314
Venezia Rocco0001104659-22-009565
SEC(opens sec.gov)

Companies

INTERCEPT PHARMACEUTICALS, INC.Chief Accounting Officer

Address

C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37

NEW YORK, NY, 10001